Lv5
1260 积分 2024-01-08 加入
Cabozantinib Carries the Risk of Drug-Drug Interactions via Inhibition of UDPglucuronosyltransferase (UGT) 1A9
5天前
已完结
Comparison of commonly used and new methods to determine small molecule non-specific binding to human liver microsomes
1个月前
已完结
Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery—A Concise Outlook
2个月前
已完结
The Prediction of the Relative Importance of CYP3A/P-glycoprotein to the Nonlinear Intestinal Absorption of Drugs by Advanced Compartmental Absorption and Transit Model
3个月前
已完结
Extrahepatic Metabolism may Complicate the IVIVC in Rats
3个月前
已完结
In Vitro–In Vivo Correlation for Low-Clearance Compounds Using Hepatocyte Relay Method
3个月前
已完结
Differential Selectivity of Efflux Transporter Inhibitors in Caco-2 and MDCK–MDR1 Monolayers: A Strategy to Assess the Interaction of a New Chemical Entity with P-gp, BCRP, and MRP2
3个月前
已完结
A Review of Current Methods for Food Effect Prediction During Drug Development
3个月前
已完结
Gender difference in the pharmacokinetics and metabolism of VX‐548 in rats
4个月前
已完结
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance
5个月前
已完结
皖公网安备34019202002308
